Skip to main content
OpenTrials

Clinical trial condition

Diffuse Cutaneous Systemic Sclerosis

Explore clinical trials studying Diffuse Cutaneous Systemic Sclerosis. Study availability and eligibility vary by location and protocol.

20 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Cutaneous Systemic Sclerosis trial results

Completed

Brentuximab Vedotin for Systemic Sclerosis

NCT03222492

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, +5 more
Locations
  • UCLA Medical Center: Division of Rheumatology Los Angeles, California, United States
  • Georgetown University Medical Center: Division of Rheumatology Washington D.C., District of Columbia, United States
  • University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology Ann Arbor, Michigan, United States
  • Hospital for Special Surgery, New York: Division of Rheumatology New York, United States
View Trial Details
Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

NCT04440592

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • Arizona Arthritis Glendale, Arizona, United States
  • Pacific Arthritis Care Center Los Angeles, California, United States
  • The Board of Trustees of the Leland Stanford Junior University Redwood City, California, United States
  • Yale School of Medicine - The Anlyan Center (TAC) for Medical Research & Education New Haven, Connecticut, United States
View all 34 locations
View Trial Details
Completed

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

NCT04137224

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Uniklinik Köln, innere Medizin Cologne, Germany
  • ASST Spedali Civili di Brescia Brescia, Italy
View Trial Details
Completed

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

NCT02161406

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • Arthritis Associates of Southern California Los Angeles, California, United States
  • University of California- Los Angeles Los Angeles, California, United States
  • Stanford University Redwood City, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View all 27 locations
View Trial Details
Completed

Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

NCT02503644

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • University Multiprofile Hospital for Active Treatment - Dr. Georgi Stranski Pleven, Bulgaria
  • Multiprofile Hospital for Active Treatment Plovdiv Plovdiv, Bulgaria
  • University Multiprofile Hospital for Active Treatment -Kaspela Plovdiv, Bulgaria
  • University Multiprofile Hospital for Active Treatment - "Sveti Ivan Rilski" Sofia, Bulgaria
View all 49 locations
View Trial Details
Active, Not Recruiting

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

NCT05270668

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease, +7 more
Locations
  • Mayo Clinic - Scottsdale ( Site 4014) Phoenix, Arizona, United States
  • Pacific Arthritis Care Center ( Site 4008) Los Angeles, California, United States
  • Cedars Sinai Medical Center ( Site 4010) Los Angeles, California, United States
  • UCLA School of Medicine ( Site 4006) Los Angeles, California, United States
View all 95 locations
View Trial Details
Active, Not Recruiting

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

NCT06255028

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +27 more
Locations
  • Keck School of Medicine of University of Southern California Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Lurie Children's; Northwestern Medicine - Northwestern Medical Group Chicago, Illinois, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details

Related conditions